Seimiya H - Search Results

1

Revisiting Telomere Shortening in Cancer.

Okamoto K, Seimiya H. Okamoto K, et al. Among authors: seimiya h. Cells. 2019 Jan 31;8(2):107. doi: 10.3390/cells8020107. Cells. 2019. PMID: 30709063 Free PMC article. Review.

2

Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.

Naasani I, Seimiya H, Tsuruo T. Naasani I, et al. Among authors: seimiya h. Biochem Biophys Res Commun. 1998 Aug 19;249(2):391-6. doi: 10.1006/bbrc.1998.9075. Biochem Biophys Res Commun. 1998. PMID: 9712707

3

Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.

Seimiya H, Oh-hara T, Suzuki T, Naasani I, Shimazaki T, Tsuchiya K, Tsuruo T. Seimiya H, et al. Mol Cancer Ther. 2002 Jul;1(9):657-65. Mol Cancer Ther. 2002. PMID: 12479362

4

Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.

Seimiya H, Muramatsu Y, Ohishi T, Tsuruo T. Seimiya H, et al. Cancer Cell. 2005 Jan;7(1):25-37. doi: 10.1016/j.ccr.2004.11.021. Cancer Cell. 2005. PMID: 15652747 Free article.

5

The telomeric PARP, tankyrases, as targets for cancer therapy.

Seimiya H. Seimiya H. Br J Cancer. 2006 Feb 13;94(3):341-5. doi: 10.1038/sj.bjc.6602951. Br J Cancer. 2006. PMID: 16421589 Free PMC article. Review.

6

Expression of mutant RPA in human cancer cells causes telomere shortening.

Kobayashi Y, Sato K, Kibe T, Seimiya H, Nakamura A, Yukawa M, Tsuchiya E, Ueno M. Kobayashi Y, et al. Among authors: seimiya h. Biosci Biotechnol Biochem. 2010;74(2):382-5. doi: 10.1271/bbb.90496. Epub 2010 Feb 7. Biosci Biotechnol Biochem. 2010. PMID: 20139621 Free article.

7

Telomere length influences cancer cell differentiation in vivo.

Hirashima K, Migita T, Sato S, Muramatsu Y, Ishikawa Y, Seimiya H. Hirashima K, et al. Among authors: seimiya h. Mol Cell Biol. 2013 Aug;33(15):2988-95. doi: 10.1128/MCB.00136-13. Epub 2013 May 28. Mol Cell Biol. 2013. PMID: 23716593 Free PMC article.

8

Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture.

Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M, Oshimura M, Ishigaki Y, Hamasaki K, Kodama Y, Yuasa S, Fukuda K, Hirashima K, Seimiya H, Koyama H, Shimizu T, Takemoto M, Yokote K, Goto M, Tahara H. Shimamoto A, et al. Among authors: seimiya h. PLoS One. 2014 Nov 12;9(11):e112900. doi: 10.1371/journal.pone.0112900. eCollection 2014. PLoS One. 2014. PMID: 25390333 Free PMC article.

9

G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells.

Hasegawa D, Okabe S, Okamoto K, Nakano I, Shin-ya K, Seimiya H. Hasegawa D, et al. Among authors: seimiya h. Biochem Biophys Res Commun. 2016 Feb 26;471(1):75-81. doi: 10.1016/j.bbrc.2016.01.176. Epub 2016 Feb 1. Biochem Biophys Res Commun. 2016. PMID: 26845351 Free PMC article.

10

Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.

Fujiwara C, Muramatsu Y, Nishii M, Tokunaka K, Tahara H, Ueno M, Yamori T, Sugimoto Y, Seimiya H. Fujiwara C, et al. Among authors: seimiya h. Sci Rep. 2018 Oct 4;8(1):14827. doi: 10.1038/s41598-018-33139-x. Sci Rep. 2018. PMID: 30287851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page